Xeos specializes in providing real-time molecular intelligence for cancer surgery, particularly in surgical oncology. Their flagship product, the XEOS AURA 10, is the first PET-CT Specimen Imager for the OR, offering high-quality imaging capabilities that combine the sensitivity of PET imaging with submillimeter spatial resolution. This innovation enables surgeons and imaging specialists to perform specimen imaging with unprecedented confidence, directly benefiting patient care.
We're tracking XEOS's market expansion
How XEOS's international expansion compares to its competitors
XEOSYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 XEOSYou | 0 | 0 | — | 0 | 0 |
Clinical Scientist
View postingGhent, Flemish Region, Belgium · 3mo ago
Strategic Account Manager (Europe)
View postingGhent Metropolitan Area · 10mo ago
DevOps Engineer
View postingGhent, Flemish Region, Belgium · last yr.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
No recent news
Sign up to track this company and get alerted the moment something changes.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about XEOS's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
